Since first reported by Mannheimer et al. (1952) anticonvulsant megaloblastic anwmia has been found to occur in between 0.15% and 0.75% of epileptic patients. It is usually associated with diphenylhydantoin (DPH) therapy, but can occur with either phenobarbitone or primidone alone. It is always due to folic acid deficiency, although there may be secondary changes in vitamin B12 metabolism. Although the aneemia is uncommon, evidence of drug-induced disturbance of folate metabolism can be found in the majority of epileptic patients (Chanarin 1969 , Reynolds 1972 . Macrocytosis in the peripheral blood film and early megaloblastic change in the sternal marrwo has been detected in up to one-third of patients. Subnormal serum folate levels have been reported in from 27 % to 91 % of epileptics (usually over 50%) and these changes are accompanied by a corresponding fall in both red cells and cerebrospinal fluid folate levels. There is an inverse correlation between folate and DPH, and to a lesser extent phenobarbitone levels, in both serum and CSF. Serum vitamin B12 levels are usually within the normal range, although they may fall in some patients following treatment with folic acid.
The mechanism by which the drugs affect folate metabolism is still uncertain. Hypotheses that have been proposed are: (1) Competitive interaction between the drugs and folate coenzymes.
(2) Malabsorption of folic acid. (3) Induction of hepatic enzymes involved in folic acid metabolism (as suggested for anticonvulsant vitamin D deficiency). (4) Increased demand for folic acid either for hydroxylation of anticonvulsant drugs or for other hepatic enzymes induced by the drugs.
Although there are reports that folic acid therapy may aggravate epilepsy in some patients, several controlled trials have not confirmed this. However, it seems there is a considerable blood brain barrier mechanism to the uptake of the vitamin and despite 3 months' oral therapy there may be no rise in CSF folate, notwithstanding considerable elevation of serum folate (Spaans 1970) .
In experimental studies, the vitamin has been shown consistently to reverse the effects of DPH and phenobarbitone (Spector 1972 , Smith & Racusen 1973 . Furthermore, there is evidence that folic acid and its derivatives have convulsant properties in their own right, especially when the blood brain barrier mechanism is damaged or circumvented (Obbens 1973) . It is therefore possible that the antifolate and antiepileptic actions of the drugs are at least partially related (Reynolds 1967).
